SecBot SecBot
8-K ·Filed May 7, 2026

INSM

INSMED Inc
BULLISH
Impact 6/10
Horizonweeks Processed6mo ago SEC0001140361-26-019430
8-K Item 2.02: Earnings release
Actionable Insight ▲ Bullish

Stock likely to rise on EPS beat and strong BRINSUPRI launch metrics. Monitor ENCORE sNDA submission in H2 2026 and TPIP data in Q3 2026 for further catalysts.

DirectionBullish
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered BULLISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$105.00
T+0 close · May 7, 2026 · via day close
Latest settled
−6.24%
T+60 · $98.45
Vs SPY
−10.07%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 7 $105.00entry
  2. T+1 · 6mo ago −3.48%α −4.31% · $101.35
  3. T+5 · 6mo ago +12.37%α +10.87% · $117.99
  4. T+20 · 6mo ago −1.09%α −4.22% · $103.86
  5. T+60 · 4mo ago −6.24%α −10.07% · $98.45
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Insmed reported Q1 2026 total revenue of $306.0M (up 230% YoY, driven by BRINSUPRI launch) and a net loss of $163.6M ($0.76 per share), beating consensus EPS of -$0.90. The company reiterated 2026 BRINSUPRI revenue guidance of at least $1B and ARIKAYCE guidance of $450-470M, and highlighted positive ENCORE Phase 3b results. The stronger-than-expected launch trajectory and EPS beat are positive catalysts.

Key Financial Metrics

EPS
−$0.76
est −$0.90 · +15.6%
Revenue
$306.0M
+230.0% YoY
Rating
beat
Guidance
BRINSUPRI: ≥$1B; ARIKAYCE: $450M-$470M
maintained

Key Facts

  • Total Q1 2026 revenue: $306.0M vs $92.8M in Q1 2025 (+230% YoY)
  • BRINSUPRI revenue: $207.9M (+44% vs Q4 2025)
  • ARIKAYCE revenue: $98.1M (+6% vs Q1 2025)
  • Net loss: $163.6M ($0.76 per share) vs $256.6M ($1.42) in Q1 2025
  • EPS beat consensus of -$0.90 by 15.6%
  • Reiterated 2026 BRINSUPRI revenue ≥$1B and ARIKAYCE $450-470M
  • Phase 3b ENCORE study met all primary and secondary endpoints
  • Cash, cash equivalents, and marketable securities: $1.2B as of March 31, 2026

Financial Impact

EPS beat by $0.14 (15.6%) on consensus -$0.90; revenue beat unknown due to lack of consensus

revenueepsguidance

Risk Factors

  • Still unprofitable with operating loss of $153.3M in Q1 2026
  • Cash burn expected to continue, though path to cash flow positive in 2027
  • Dependence on BRINSUPRI launch momentum and label expansion for ARIKAYCE

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
96% bullish (26 analysts)

Investment Themes

Documents Analyzed

This report is based on 7 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001140361-26-019430
Document: ef20072589_ex99-2.htm0001140361-26-019430
Document: ef20072589_8k.htm0001140361-26-019430
Document: 0001140361-26-019430-index-headers.html0001140361-26-019430
Document: 0001140361-26-019430-index.html0001140361-26-019430
Document: 0001140361-26-019430.txt0001140361-26-019430
8-K Data (Synthetic)0001140361-26-019430

Track record

24 reports on INSM

Performance horizon

5 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +31.86% at T+60 after the Mar 30, 2026 report. 7 of 8 went positive at some point.

Filters
  1. Nov 3, 202613d ago 144 Neutral 2/10 Entry $110.00 Now $122.88 +11.71% settles Dec 3
  2. Nov 3, 202613d ago 3 Neutral 1/10 Entry $110.00 Now $122.88 +11.71% settles Dec 3
  3. Oct 29, 202618d ago 8-K Bullish 6/10 Entry $111.59 Now $122.88 +10.12% settles Nov 27
  4. Oct 20, 202627d ago Institutional Cluster Bullish 4/10 Entry $94.04 Now $122.88 +30.67% settles Nov 18
  5. Oct 20, 202627d ago 8-K Neutral 3/10 Entry $95.67 Now $122.88 +28.44% settles Nov 17
  6. Oct 5, 20266w ago 8-K Neutral 4/10 Entry $103.83 to $112.58 Now $122.88 +18.35% ▲ +8.43% +10.89% vs SPY
  7. Aug 19, 202612w ago Insider Cluster Neutral 4/10 Entry $125.08 to $120.00 Now $122.88 −1.76% ▼ −4.06% −4.19% vs SPY
  8. Aug 12, 202613w ago Insider Cluster Neutral 4/10 Entry $126.33 to $129.41 Now $122.88 −2.73% ▲ +2.44% +4.19% vs SPY
  9. Aug 6, 202614w ago 8-K Bullish 8/10 Entry $132.55 to $126.68 Now $122.88 −7.30% ▼ −4.43% −5.03% vs SPY
  10. Jul 24, 202616w ago Institutional Cluster Neutral 4/10 Entry $106.92 to $125.77 Now $122.88 +14.93% ▲ +17.63% +14.00% vs SPY
Showing 10 of 24

US Market Status

Market Closed · Opens Wed (11h 17m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 7, 2026